Last reviewed · How we verify
NCT06210399
Shockwave Therapy in Patients With Chronic Wounds
NA trial testing Extracorporeal Shockwave Therapy in Wound Heal in 31 participants. Completed in 31 January 2025.
31 January 2025
Quick facts
| Lead sponsor | Guadarrama Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 31 |
| Start date | 1 November 2023 |
| Primary completion | 31 January 2025 |
| Estimated completion | 31 January 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Extracorporeal Shockwave Therapy
Conditions studied
- Wound Heal — all drugs for Wound Heal →
Sponsor
Guadarrama Hospital
Who can join
18 and older, any sex, with Wound Heal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Chronic wounds are a major health problem with impact in the quality of life of patients, increased their morbidity and mortality, nursing burden, extend the hospital stays, and healthcare costs. Searching how to apply the best care available in wounds, shock wave treatment is found in order to stimulate tissue growth in this type of skin injuries. There are different studies to support this recommendation but also there is variability about of patients, different types of injuries or settings. It is considered that more research studies are needed to maintain this evidence and to explore other settings like the effectiveness in a medium stay hospital. Objectives: To assess the effectiveness of shockwave treatment to reduce the size of chronic wounds. Method: A quasi-experimental design will be used. The population under study will include patients admitted in the Functional Recovery Unit who present chronic wounds upon admission. The sample size will be 30 patients. An intentional non-probabilistic sampling will be carried out. Main outcome: decrease the wound size. Sociodemographic variables, personal history, comorbidities, current clinical situation, shock wave treatment variables and its evolution will be collected. Applicability: In case of findings are better than habitually care, the number of treatments required by the patient would be reduced, the patient's state of health would improve, the risk of infection of the wound decrease, and the comfort and quality of life of patients could improve. The findings may represent a change in clinical practice because they may be used to modify the treatment protocols for chronic wounds at the Guadarrama Hospital and in other similar hospitals. Also, they can contribute to the evidence based care which supports shockwave treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06210399
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Extracorporeal Shockwave Therapy
Trials testing the same drug.
- NCT07483320 — Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy · NA · not yet recruiting
- NCT07317297 — Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease · NA · recruiting
- NCT07196267 — Shockwave and Cryoflow for Shoulder Pain After Stroke · NA · completed
- NCT06548321 — Benefits of Extracorporeal Shockwave Therapy to Reduce Spasticity in Stroke/CP · NA · active not recruiting
- NCT06898125 — Evaluation of Extracorporeal Shockwave Therapy and Complex Decongestive Therapy Results in Patients With Lipedema · NA · completed
Other recruiting trials for Wound Heal
Currently open trials in the same condition.
- NCT07261501 — An Exploratory Research on the Efficacy and Safety of Antibacterial Absorbable Dressing in Chronic Non-healing Wounds · NA · recruiting
- NCT07209358 — EDX110 Randomized Control Trial for Treatment of DFUs · NA · recruiting
- NCT06522438 — Hyaluronic Acid and Octenidine Gel as an Adjunct to Non-surgical Periodontal Treatment · NA · recruiting
- NCT06841237 — Randomized Controlled Trial on the Efficacy and Safety of Xiang Lei Ointment in Diabetic-related Ulcer Management · NA · recruiting
- NCT06563323 — Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) · Phase 2 · recruiting
Other Guadarrama Hospital trials
Trials by the same sponsor.
- NCT07125430 — Shock Wave Treatment in Patients With Knee Osteoarthritis · NA · recruiting
- NCT04553822 — Mucociliary Clearance Techniques in Moderate Bronchiolitis · NA · completed
- NCT04117126 — Efficacy of Prompted Voiding Therapy in Elderly Hospitalized. · NA · completed
- NCT03835858 — Safety of Airway Clearance in Non-hospitalized Infants With Acute Viral Bronchiolitis · NA · completed
- NCT03835936 — Treatment of Pediatric Bronchiolitis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06210399 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guadarrama Hospital
- Last refreshed: 25 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06210399.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing